Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies.
Viktoria StühlerLisa HerrmannMoritz MaasSimon WalzSteffen RauschArnulf StenzlJens BedkePublished in: World journal of urology (2022)
Despite the progress of IO-based combination therapies in first line, complete metastasectomy remains an integral part of the multimodality treatment of metastatic RCC.